Анестезия и педиатрия - Джордж А.Г.
ISBN 5-225-03821-2
Скачать (прямая ссылка):
65. Way WL, Cost ley EC, Way EL Respiratory sensitivity of newborn infants to meperidine and morphine. Clin Pharmacol Ther 6:454, 1965
66. Gladtke E, Heimann G: The rate of development of elim-
вО Анестезия в педиатрии
ination (Unctions of kidney and liver of young infants, p. 393. In Morselli PL, Carattini S, Sereni F(eds): Basic and Therapeutic Aspects of Perinatal Pharmacology. Raven Press, New York. 1975. p. 393
67. Morselli PL, Principi N, Togoni G et al: Diazepam elimination in premature and full term infants and children. J Perinat Med 1:167. 1973
68. MefFin P, Long GL, Thomas J: Clearance and metabolism of mepivacaine in the human neonate. Clin Pharmacol Ther 14:218, 1973
69. Alan SN, Roberts RJ, Fischer U: Age related differences in salicylamide and acetaminophen conjugation in man. J Pediatr 1:30, 1977
70. Jenne JW, Nagasawa HT, Thompson RD: Relationship of urinary metabolites of theophylline to serum theophylline levels. Clin Pharmacol Ther 19:453, 1968
71. Sereni F, Principi N: Developmental pharmacology. Annu Rev Pharmacol 8:453, 1968
72. Levy G, Khan па NN, Soda DM et al: Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucinonide and sulfate in relation to plasma bilirubin concentrations and D-glucuronic acid excretion. Pediatrics 55:1461, 1966
73. Arant BS; Developmental patterns of renal functional maturation compared in the human neonate. Pediatrics 92:705, 1978
74. Arant BS Jr: Developmental patterns of renal functional maturation compared in the human neonate. J Pediatr 92:705, 1978
75. Haycoek GB: Development of glomerular filtration and tubular sodium reabsorption in the human fetus and newborn. Br J Urol 81 (Suppl 2>:33, 1998
76. Leake RD, Trygstad CW: Glomerular filtration rate during the period of adaptation to extrauterine life. Pediatr Res 11:959. 1977
77. Tognoni G: Antibiotics, p. 123. In Morselli PL<ed): Drug Disposition During Development. Spectrum, New York, 1976, p. 123
78. Gatg DC. Goldberg RN, Woo MR, Weidler DJ: Pharmacokinetics of thiopental in the asphyxiated neonate. Dev Pharmacol Ther 11:213. 1988
79. Eger El II: Anesthetic Uptake and Action. Williams & Wilkins, Baltimore, 1974
80. Eger El 1): Effect of inspired anesthetic concentration on the rate of rise of alveolar concentration. Anesthesiology 24:153, 1963
81. Avery ME, Fletcher BD: The Lung and Its Disorders in the Newborn Infant. WB Saunders, Philadelphia, 1974
82. Gibbs CP. Munson ES. Tham MK: Anesthetic solubility coefficients for maternal and fetal blood. Anesthesiology 43:100, 1975
83. Lerman J. Gregory GA, Willis MM, Egar El П: Age and solubility of volatile anesthetics in blood. Anesthesiology 61:139. 1984
84. Lerman J, Schmitt-BanteI Bl, Gregory GA et al: Effect of age on the solubility of volatile anesthetics in human tissues. Anesthesiology 65:307, 1986
85. Dobbing J, Sands J: Quantitative growth and development of human brain. Arch Dis Child 48:757, 1973
86. Widdowson EM: Changes in body composition during growth, p. 337. In Davis JA. Dobbing J (eds): Scientific Foundations of Pediatrics. 2nd Ed. William Heinmann Medical Books. London, 1981, p. 337
87. Lerman J, Gregory GA, Eger El II: Effects of anaesthesia and surgery on the solubility of volatile anaesthatics in blood. Can J Annesth 34:14, 1987
88. Cook DR, В random BW, Shin G, Wolfson B: The in-spired median effective dose, brain concentration at anesthesia, and cardiovascular index for halothane in young rats. Anesth Analg 60:182, 1981
89. Rudolph AM: Congenital Diseases of the Heart. Year Book Medical Publishers. Chicago, 1974
90. Salanitre E, Rackow H: The pulmonary exchange of nitrous oxide and halothane in infants and children. Anesthesiology 30:338, 1969
91. Steward Dl, Creighton RE: The uptake of nitrous oxide in the newborn. Can Anaesth Soc J 25:215, 1978
92. Rackow H, Salanitre E: The pulmonary equilibration of cyclopropane in infants and children. Br і Anaesth 46:35,
1974
93. Deming MV: Agents and techniques for induction of anesthesia in infants and young children. Anesth Analg 31:113, 1952
94. Lerman J, Robinson S, Willis MM, Gregory GA: Anesthetic requirements for halothane in young children 0— I month and 1—6 months of age. Anesthesiology 59:421,
1983
95. LeDez KM, Lerman J: The minimum alveolar concent ration (MAC) of isoflurane in preterm neonates. Anesthesiology 67:301, 1987
96. Cameron CB, Robinson S, Gregory GA: The minimum anesthetic concentration of isoflurane in children. Anesth Analg 63:418, 1984
97. Gregory GA Eger El, Munson ES: The relationship between age and halothane requirement in man. Anesthesiology 30:488, 1969
98. Nicodemus N F, Nassiri-Rhimi C, Bachman L: Median effective doses (EDm) of halothane in adults and children. Anesthesiology 31:344, 1969
99. Katoh T, Ikeda K: Minimum alveolar concentration of sevoflurane in children. Br J Anaesth 68:139, 1992
100. Fisher DM, Zwass M: MaC ofdesflurane in 60 % nitrous oxide in infants and children. Anesthesiology 76:354, 1992
